Dialyse aktuell 2009; 13(6): 334-337
DOI: 10.1055/s-0029-1237457
Forum der Industrie

© Georg Thieme Verlag KG Stuttgart ˙ New York

Neues vom Weltkongress der Nephrologie 2009 - Selektive VDR-Aktivierung und kardiorenales Syndrom - ein Paradigmenwechsel

Further Information

Publication History

Publication Date:
03 August 2009 (online)

Also available at
 

Ein bedeutsames und unter den Teilnehmern intensiv diskutiertes Thema auf dem "World Congress of Nephrology" (WCN) 2009 Ende Mai in Mailand war die selektive VDR-Aktivierung (VDR: Vitamin-D-Rezeptor) und ihre positiven Effekte, insbesondere hinsichtlich der Kardio- und Renoprotektion. Drei international renommierte Experten, Prof. Eduardo Slatopolsky (USA), Prof. Illka Pörsti (Finnland) und Prof. Bruce Hendry (Großbritannien), gaben im Rahmen eines Symposiums der Firma Abbott auf dem WCN ein Update.

Literatur

  • 01 Brown AJ . Finch J . Slatopolsky E . Differential effects of 19-nor-1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 on intestinal calcium and phosphorus transport.  J Lab Clin Med. 2002;  139 279-284
    Google Scholar
  • 02 Cardús A . Panizo S . Parisi E . et al . Differential effects of vitamin D analogues on vascular calcification.  JBMR. 2007;  22 860-866
    Google Scholar
  • 03 Bodyak N . Ayus JC . Achinger S . et al . Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.  Proc Natl Acad Sci USA. 2007;  104 16810-16815
    Google Scholar
  • 04 Agarwal R . Acharya M . Tian J . et al . Antiproteinuric effect of oral paricalcitol in chronic kidney disease.  Kidney Int. 2005;  68 2823-2828
    Google Scholar
  • 05 Alborzi P . Patel NA . Peterson C . et al . Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial.  Hypertension. 2008;  52 249-255
    Google Scholar
  • 06 Tan X . Li Y . Liu Y . Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.  J Am Soc Nephrol. 2006;  17 3382-3393
    Google Scholar
  • 07 Husain K . Ferder L . Mizobuchi M . et al . Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.  Am J Nephrol. 2009;  29 465-472
    Google Scholar
  • 08 Ronco C . Haapio M . House AA . et al . Cardiorenal syndrome.  J Am Coll Cardiol. 2008;  52 1527-1539
    Google Scholar
  • 09 Resnick LM . Müller FB . Laragh JH . et al . Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism.  Ann Intern Med. 1986;  105 649-654
    Google Scholar
  • 10 Freundlich M . Quiroz Y . Zhang Z . et al . Suppression of renin-angiotensin gene expression in the kidney by paricalcitol.  Kidney Int. 2008;  74 1394-1402
    CrossrefGoogle Scholar
  • 11 Zhang Z . Zhang Y . Ning G . et al . Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.  Proc Natl Acad Sci USA. 2008;  105 15896-15901
    CrossrefGoogle Scholar
  • 12 Repo JM . Rantala IS . Honkanen TT . et al . Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol.  Kidney Int. 2007;  72 977-984
    CrossrefGoogle Scholar
  • 13 Matias PJ . Ferreira C . Jorge C . et al . 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients.  Nephrol Dial Transplant. 2009;  24 611-618
    Google Scholar
  • 14 Wu-Wong JR . Nakane M . Ma J . et al . Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.  Am J Physiol Renal Physiol. 2007;  293 F1592-F1604
    CrossrefGoogle Scholar
  • 15 Teng M . Wolf M . Lowrie E . et al . Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.  N Eng J Med. 2003;  349 446-456
    CrossrefGoogle Scholar
  • 16 Lambers Heerspink HJ . Agarwal R . Coyne DW . et al . The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) study: Study design and baseline characteristics.  Am J Nephrol. 2009;  30 280-286
    CrossrefGoogle Scholar
      >